CompletedPhase 2NCT01300923

Acamprosate in Youth With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Indiana University
Principal Investigator
Craig A. Erickson, M.D.
Indiana University School of Medicine - Department of Psychiatry
Intervention
Acamprosate(drug)
Enrollment
14 enrolled
Eligibility
5-17 years · All sexes
Timeline
20102011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01300923 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials